|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$81,542.32 |
2.73% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$79,860.82 |
2.68% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$78,661.26 |
2.64% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$78,565.20 |
2.63% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,616.85 |
2.47% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$72,607.30 |
2.43% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$71,778.74 |
2.41% |
| Waters Corporation |
WAT |
941848103 |
184 |
$68,987.12 |
2.31% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$68,560.82 |
2.30% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$67,757.97 |
2.27% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$67,274.82 |
2.26% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$66,703.29 |
2.24% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$66,502.92 |
2.23% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$65,985.18 |
2.21% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$65,442.06 |
2.19% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$63,948.18 |
2.14% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$62,974.80 |
2.11% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$62,646.24 |
2.10% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$62,328.96 |
2.09% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$61,717.50 |
2.07% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,769.83 |
2.04% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$60,961.16 |
2.04% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$60,198.90 |
2.02% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$60,385.55 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$59,706.60 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$59,524.92 |
2.00% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$58,361.05 |
1.96% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$58,301.55 |
1.95% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,374.76 |
1.92% |
| Steris Plc |
STE |
G8473T100 |
265 |
$57,078.35 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$56,669.08 |
1.90% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,659.18 |
1.90% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$56,695.50 |
1.90% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$56,596.53 |
1.90% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$56,353.92 |
1.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$55,549.00 |
1.86% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$54,445.43 |
1.83% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$54,329.80 |
1.82% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$53,603.61 |
1.80% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$53,626.50 |
1.80% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$53,109.40 |
1.78% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$52,366.23 |
1.76% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$51,397.16 |
1.72% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,739.88 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$48,465.00 |
1.62% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,516.53 |
1.56% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$44,942.99 |
1.51% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$43,261.50 |
1.45% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$42,629.53 |
1.43% |
| US Dollar |
$USD |
|
14,464 |
$14,464.19 |
0.48% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|